b2venture is an early-stage venture capital firm primarily investing in Seed and Series A technology companies across Europe. They focus on supporting founders with operational expertise and a strong network to build global leaders.
Portfolio
8
Fund Size
$1B
Top Stage
Pre Seed
Last 12 Mo
2
Team
Stage Distribution
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| 1KOMMA5° | Growth | $150M | Jul 2025 |
| Kiin Bio | Pre-Seed | $1.9M | Jun 2025 |
| 1Komma5 | Growth | $150M | Dec 2024 |
| Quanta Dialysis Technologies | Series E | $60M | Nov 2024 |
| Orus Energy | Pre-Seed | $2.4M | Jul 2024 |
| Aeovian Pharmaceuticals | Series C | $50M | Mar 2024 |
| Yendou | Pre-Seed | $1.3M | Feb 2024 |
| Nelly | Series A | $15M | Jun 2023 |
Top Co-Investors
Hamilton Lane2 shared
Eurazeo2 shared
eCAPITAL2 shared
Lakestar1 shared
Motive Partners1 shared
G2 Venture Partners1 shared
Norrsken VC1 shared
Apollo Health Ventures1 shared
Sofinnova Partners1 shared
venBio1 shared
Novo Holdings1 shared
Sabanci Climate Ventures1 shared
G2VP1 shared
Porsche Investments1 shared
Last updated: 1 March 2026